Histology And Cytology Market Size, Share & Trends Report

Histology And Cytology Market Size, Share & Trends Analysis Report By Type Of Examination (Histology, Cytology), By Product (Instruments, Consumables), By Application, By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-1-68038-917-3
  • Number of Pages: 196
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Research Methodology

A three-pronged approach was followed for deducing the histology and cytology market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for histology and cytology market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of histology and cytology market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Histology And Cytology Market Categorization:

The histology and cytology market was categorized into four segments, namely type of examination (Histology, Cytology, ), product (Instruments And Analysis Software System, Consumable And Reagents), application (Drug Discovery & Designing, Clinical Diagnostics, Research), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). 

Segment Market Methodology:

The histology and cytology market was segmented into type of examination, product, application, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The histology and cytology market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; Germany; the UK; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; South Korea; Thailand; Australia; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; and Kuwait

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Histology and cytology market companies & financials:

The histology and cytology market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • HOLOGIC, INC - Women’s health surgical products, medical imaging instruments, and diagnostics are manufactured and supplied by Hologic Inc. The company functions through four business divisions which include gynecologic surgical, skeletal health, diagnostic, and breast health. The products of the company are sold through a fusion of direct sales and a network of independent distributors and representatives. Aptima assays, ThinPrep system, Procleix Zika virus assay, and fetal fibronectin test are included within the diagnostics business. ThinPrep System is primarily used in cytology applications such as cervical cancer screening.

  • F. HOFFMANN-LA ROCHE LTD. - a comprehensive array of diagnostic tests is offered by F. Hoffmann-La Roche Ltd. The diagnostics division of the company encompasses clinical chemistry & immunoassay, urinalysis, hematology & hemostasis, molecular diagnostics, tissue diagnostics, and point-of-care diagnostics. The company also concentrates on prevalent diseases such as cancer, cardiology & metabolism, infectious diseases, inflammatory & autoimmune, women’s health, and critical care. F. Hoffmann-La Roche Ltd. operates in various regions including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. At present, the Roche Group maintains 22 research and development locations and 26 production facilities globally.

  • ABBOTT - Abbott is a company in the healthcare sector that focuses on the creation of products and technologies. It has operations in key healthcare areas such as medical devices, diagnostics, nutrition, and branded generic pharmaceuticals. The diagnostics division of Abbott provides a wide range of products including immunoassay, hematology, clinical chemistry, blood screening, point-of-care, and informatics. Additionally, Abbott PRISM, a brand in the blood screening segment, is also offered by the company. Abbott has a global presence with operations in North America, Europe, and Asia Pacific. To broaden its diagnostics business, Abbott successfully acquired Alere, Inc. in September 2017.

  • MERCK KGAA - With a rich history spanning nearly 350 years, Merck KGaA stands as one of the world's most seasoned entities in the chemical and pharmaceutical industry. This science and technology firm is structured into three core sectors: healthcare, life sciences, and performance materials, which collectively house its six business divisions. Globally, the company is recognized by the name Merck, except the U.S. and Canada. In these territories, it operates under different names: EMD Serono for its biopharmaceutical operations, MilliporeSigma for its life sciences division, and EMD Performance Materials for its high-tech materials industries.

  • THERMO FISHER SCIENTIFIC, INC. - The amalgamation of Thermo Electron and Fisher Scientific established Thermo Fisher Scientific, Inc. is a product of. The firm provides a comprehensive and cohesive array of services and solutions for clinical science, healthcare, and laboratory research & analysis. It produces items that are tailored to four key business sectors: analytical instruments, laboratory products & services, life sciences solutions, and specialty diagnostics. The specialty diagnostics division offers a variety of culture media, diagnostic kits, instruments, reagents, and other products that cater to clients in food safety labs, healthcare, industrial, pharmaceutical, and clinical settings. This business division is further divided into six main businesses: clinical diagnostics, healthcare market channels, immunodiagnostics, microbiology, transplant diagnostics, and anatomical pathology. The anatomical pathology division provides products used in cytology, hematology, and histology applications for medical research and cancer diagnosis. Thermo Fisher Scientific also earns revenue through its fully-owned subsidiaries such as Applied Biosystems, Fisher Scientific, Invitrogen, and Unity Lab Services. The company has operations in over 150 countries spanning Asia, Europe, Latin America, and North America.

  • SYSMEX CORPORATION - Sysmex Corporation is engaged in the creation, production, and distribution of diagnostic tools, reagents, & software, and it exports to over 190 countries globally. The company has a presence in the Middle East through its subsidiary and employs a direct sales approach. Its clientele comprises research institutions, national & public hospitals, private hospitals, universities, and medical institutions. Sysmex has established a worldwide network for both direct and indirect sales, manufacturing of reagents, and provision of support services. The company is expanding its operations in developing economies and has a network of 63 group companies functioning in 41 nations worldwide.

  • TRIVITRON HEALTHCARE - Medical technology that is committed to creating cost-effective healthcare solutions is manufactured by Trivitron Healthcare. It ranks among the largest unified corporate healthcare entities in India. The firm also has a presence in regions such as the UAE, Europe, Africa, the Middle East, Turkey, South East Asia, and the U.S. Trivitron Healthcare produces and distributes medical technology goods in 165 countries. The company prioritizes innovation in areas such as imaging & radiology, critical care, solutions associated with the operating room, in vitro diagnostics, radiation protection, and newborn screening. Trivitron Healthcare operates via nine manufacturing facilities that have been granted certifications by the U.S. FDA and CE, in addition to numerous R&D partnerships with prominent businesses.

  • KONINKLIJKE PHILIPS N.V. - Formerly known as Koninklijke Philips Electronics N.V., Koninklijke Philips N.V. is a tech firm that offers products for integrated clinical solutions, advanced molecular imaging, diagnostic imaging solutions, and image-guided therapy solutions & therapy devices. The business segment of diagnosis and treatment comprises ultrasound, image-guided therapy, and diagnostic imaging, with diagnostic imaging representing 50% of the total diagnosis and treatment business in 2016. Image-guided therapy and ultrasound made up 29% and 21% of the share, respectively. Additionally, the company provides digital pathology solutions that assist pathologists and enhance efficient workflow.

  • DANAHER CORPORATION - Involved in the design, production, and marketing of products and services for commercial, professional, and medical applications, DANAHER operates in four divisions. These four segments include diagnostics, life sciences, environmental & applied solutions, and dental solutions. The diagnostics division of Danaher provides consumables, software, analytical instruments, reagents, and services for diagnosing various diseases in critical care settings, hospitals, physicians’ offices, and reference laboratories. In 2016, North America accounted for 38% of the diagnostics share. Danaher has facilities in over 60 countries worldwide. In 2005, Danaher took over Leica Biosystems Nussloch GmbH. The company’s offerings span areas such as immunohistochemistry, digital pathology, surgery, clinical microscopy, in situ hybridization, FISH, histology equipment & consumables, and radiology.

  • BECTON, DICKINSON & COMPANY - A manufacturer of medical technologies, Becton, Dickinson, and Company, is based in the U.S. The company's main business divisions fall under two categories: BD Medical and BD Life Sciences. BD Medical offers medical devices that are appropriate for a variety of healthcare environments. The key business units of BD Life Sciences include preanalytical systems, diagnostic systems, and biosciences. The company's operations of manufacturing and selling are conducted globally in over 190 countries. In addition to the U.S., the company has operations in regions such as Europe, the Middle East & Africa, Asia, Latin America, and Canada.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Histology And Cytology Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Histology And Cytology Market Report Assumptions:

  • The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation



This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.



We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member


ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon